Homebiotech

biotech

biotech

Paediatric pneumococcal vaccine programme advancing

Jim Cornall - May 28, 2026

biotech

FDA clearance for universal dual-target CAR-T candidate

Jim Cornall - May 28, 2026

biotech

Positive data from chronic scrotal content pain trial

Jim Cornall - May 28, 2026

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026

biotech

Hepatocellular carcinoma in the crosshairs with new treatment

Jim Cornall - August 6, 2025

biotech

A new path in cancer immunotherapy

Jim Cornall - August 6, 2025

biotech

Dx&Vx signs co-development and license agreement for mRNA cancer vaccine

Jim Cornall - August 5, 2025

biotech

Fast Track designation for severe alopecia areata treatment

Jim Cornall - August 5, 2025

biotech

Boehringer Ingelheim and Re-Vana Therapeutics to collaborate on ophthalmic therapies

Jim Cornall - August 5, 2025

biotech

MapLight Therapeutics raises $372.5m

Jim Cornall - August 4, 2025

biotech

Positive results for Energenesis Biomedical Parkinson’s disease treatment

Jim Cornall - August 4, 2025

biotech

Biotech tests in space?

Jim Cornall - August 4, 2025

1...636465...79 Page 64 of 79

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Paediatric pneumococcal vaccine programme advancing

Jim Cornall - May 28, 2026 0

Pfizer Inc. has announced data from its phase 2 study evaluating the safety, tolerability and immunogenicity of a four-dose series of its investigational 25-valent...

FDA clearance for universal dual-target CAR-T candidate

biotech Jim Cornall - May 28, 2026 0

Positive data from chronic scrotal content pain trial

biotech Jim Cornall - May 28, 2026 0

Thalassaemia treatment gets EU approval

biotech Jim Cornall - May 27, 2026 0

New data from Parkinson’s disease trial

biotech Jim Cornall - May 27, 2026 0